跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
TIORFAN INFANTIL 4 MG/ML SUSPENSIÓN ORAL - CIMA-AEMPS Drug Approval Details
Approvals
/
CIMA-AEMPS
/
TIORFAN INFANTIL 4 MG/ML SUSPENSIÓN ORAL
Approved
STANDARD
TIORFAN INFANTIL 4 MG/ML SUSPENSIÓN ORAL
Bioprojet Pharma
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Feb 6, 2024
Approval ID
417db179124e8e1a
Company
Bioprojet Pharma
Type
Standard
Approval Details
Approval Id
417db179124e8e1a
Drug Cima Aemps Name
TIORFAN INFANTIL 4 MG/ML SUSPENSIÓN ORAL
Register Number
88685
Holder Company Name
Bioprojet Pharma
Marketing Company Name
Bioprojet Pharma
Holder Company Detail Path
/organization/bioprojet-pharma
Marketing Company Detail Path
/organization/bioprojet-pharma
Authorization Date
2024-02-06
Dosage Form
SUSPENSIÓN ORAL
Dose
4 mg/ml
Route Of Administration
VÍA ORAL
Prescription Type
Medicamento Sujeto A Prescripción Médica
Commercialized
No
Company Name
Bioprojet Pharma
Company Detail Path
/organization/bioprojet-pharma
Company Information
Pharmaceutical Company Name
Bioprojet Pharma
Country Name
Belgium
City Name
unknown,unknown,country_be
Address
Unknown Belgian address
Active Ingredients
RACECADOTRILO
4 mg/ml
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Feb 6, 2024
Approval ID
417db179124e8e1a
Type
Standard
Back to CIMA-AEMPS Approvals